|
|
EVALUATION OF BIOFLUID EXRNA ISOLATION BY SMALL RNASEQ |
| 3UH3TR000890-04S2 |
GANDHI, ROOPALI |
NCATS |
2016 |
|
|
EXOSOME RNA-THERAPEUTICS TO PROMOTE CNS MYELINATION |
| 3UH3TR000918-04S1 |
KRAIG, RICHARD P |
NCATS |
2016 |
|
|
CIRCULATING MICRORNAS AS DISEASE BIOMARKERS IN MULTIPLE SCLEROSIS |
| 5UH3TR000890-04 |
WEINER, HOWARD L |
NCATS |
2016 |
|
|
EXOSOME RNA-THERAPEUTICS TO PROMOTE CNS MYELINATION |
| 5UH3TR000918-04 |
KRAIG, RICHARD P |
NCATS |
2016 |
|
|
THERAPEUTIC STRATEGY FOR LAM (LYMPHANGIOLEIOMYOMATOSIS) |
| 5UH3TR000961-03 |
EISSA, N. TONY |
NCATS |
2016 |
|
|
NEUROBIOLOGICAL & CLINICAL PHENOTYPES IN OEF/OIF/OND VETERANS WITH MTBI OR BLAST |
| 1R21AT009430-01 |
MILBERG, WILLIAM P |
NCCIH |
2016 |
|
|
MICRORNA REGULATION OF EAE BY RESVERATROL |
| 5F32AT008539-03 |
GANDY, K ALEXA |
NCCIH |
2016 |
|
|
MIND-BODY THERAPIES FOR PATIENTS WITH END-STAGE RENAL DISEASE |
| 5K23AT006965-06 |
BIRDEE, GURJEET SINGH |
NCCIH |
2016 |
|
|
MINDFULNESS-BASED STRESS REDUCTION FOR MULTIPLE SCLEROSIS: FEASIBILITY, DURABILITY, AND CLINICAL OUTCOMES |
| 5K23AT008211-02 |
SENDERS, ANGELA |
NCCIH |
2016 |
|
|
MECHANISMS OF HUMAN IMMUNE MODULATION BY ORAL N-ACETYLGLUCOSAMINE |
| 5R01AT007452-03 |
DEMETRIOU, MICHAEL |
NCCIH |
2016 |
